These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1850424)

  • 1. Human 92- and 72-kilodalton type IV collagenases are elastases.
    Senior RM; Griffin GL; Fliszar CJ; Shapiro SD; Goldberg GI; Welgus HG
    J Biol Chem; 1991 Apr; 266(12):7870-5. PubMed ID: 1850424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
    Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
    J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis.
    Mecham RP; Broekelmann TJ; Fliszar CJ; Shapiro SD; Welgus HG; Senior RM
    J Biol Chem; 1997 Jul; 272(29):18071-6. PubMed ID: 9218437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats.
    Shipley JM; Doyle GA; Fliszar CJ; Ye QZ; Johnson LL; Shapiro SD; Welgus HG; Senior RM
    J Biol Chem; 1996 Feb; 271(8):4335-41. PubMed ID: 8626782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.
    Goldberg GI; Marmer BL; Grant GA; Eisen AZ; Wilhelm S; He CS
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8207-11. PubMed ID: 2554304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastin degradation by mononuclear phagocytes.
    Shapiro SD; Campbell EJ; Welgus HG; Senior RM
    Ann N Y Acad Sci; 1991; 624():69-80. PubMed ID: 2064250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases.
    Campbell EJ; Cury JD; Shapiro SD; Goldberg GI; Welgus HG
    J Immunol; 1991 Feb; 146(4):1286-93. PubMed ID: 1991967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response?
    Buckmaster MJ; Curci JA; Murray PR; Liao S; Allen BT; Sicard GA; Thompson RW
    Cardiovasc Surg; 1999 Jan; 7(1):16-26. PubMed ID: 10073755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.
    DeClerck YA; Yean TD; Lu HS; Ting J; Langley KE
    J Biol Chem; 1991 Feb; 266(6):3893-9. PubMed ID: 1847392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.
    Kleiner DE; Unsworth EJ; Krutzsch HC; Stetler-Stevenson WG
    Biochemistry; 1992 Feb; 31(6):1665-72. PubMed ID: 1310615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation.
    Welgus HG; Senior RM; Parks WC; Kahn AJ; Ley TJ; Shapiro SD; Campbell EJ
    Matrix Suppl; 1992; 1():363-7. PubMed ID: 1480061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
    Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
    Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors.
    Chapman HA; Stone OL
    J Clin Invest; 1984 Nov; 74(5):1693-700. PubMed ID: 6568228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease.
    Shapiro SD
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S160-4. PubMed ID: 7952653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.
    Olson JC; Ohman DE
    J Bacteriol; 1992 Jun; 174(12):4140-7. PubMed ID: 1597429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase.
    Welgus HG; Fliszar CJ; Seltzer JL; Schmid TM; Jeffrey JJ
    J Biol Chem; 1990 Aug; 265(23):13521-7. PubMed ID: 2166034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.
    Welgus HG; Campbell EJ; Cury JD; Eisen AZ; Senior RM; Wilhelm SM; Goldberg GI
    J Clin Invest; 1990 Nov; 86(5):1496-502. PubMed ID: 2173721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.